Literature DB >> 8074807

Potent inactivation of cathepsins S and L by peptidyl (acyloxy)methyl ketones.

D Brömme1, R A Smith, P J Coles, H Kirschke, A C Storer, A Krantz.   

Abstract

Peptidyl (acyloxy)methyl ketones (Z-Aa-Aa-CH2-O-CO-R), a new class of irreversible inhibitors whose chemical reactivity can be modulated by varying the substitution pattern of the carboxylate leaving group, are shown to be extremely potent inactivators of the lysosomal cysteine proteinases cathepsin L and cathepsin S. The highest k2/Ki values measured were found to exceed 10(6) M-1s-1 for both cathepsin L and cathepsin S. The rate of inactivation can be controlled by varying the dipeptidyl moiety or the carboxylate leaving group, with the second-order rate constants for both enzymes found to be strongly dependent on the pKa values of the leaving group. The specificities of the cathepsins S and L reveal a different selectivity towards the nature of substitution of the aryl P' leaving group of the inhibitor. This new inhibitor class opens the possibility of the design of selective and specific inhibitors for lysosomal cysteine proteinases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8074807     DOI: 10.1515/bchm3.1994.375.5.343

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  3 in total

1.  Development of small molecule inhibitors and probes of human SUMO deconjugating proteases.

Authors:  Victoria E Albrow; Elizabeth L Ponder; Domenico Fasci; Miklós Békés; Edgar Deu; Guy S Salvesen; Matthew Bogyo
Journal:  Chem Biol       Date:  2011-06-24

Review 2.  Cysteine cathepsins: from structure, function and regulation to new frontiers.

Authors:  Vito Turk; Veronika Stoka; Olga Vasiljeva; Miha Renko; Tao Sun; Boris Turk; Dušan Turk
Journal:  Biochim Biophys Acta       Date:  2011-10-12

3.  Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer.

Authors:  Sheila Siqueira Andrade; Iuri Estrada Gouvea; Mariana Cristina C Silva; Eloísa Dognani Castro; Cláudia A A de Paula; Debora Okamoto; Lilian Oliveira; Giovani Bravin Peres; Tatiana Ottaiano; Gil Facina; Afonso Celso Pinto Nazário; Antonio Hugo J F M Campos; Edgar Julian Paredes-Gamero; Maria Juliano; Ismael D C G da Silva; Maria Luiza V Oliva; Manoel J B C Girão
Journal:  BMC Cancer       Date:  2016-03-01       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.